Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7,811 adverse event reports in the FDA FAERS database where RITUXIMAB was used for B-cell lymphoma.

Most Reported Side Effects for RITUXIMAB

Side Effect Reports % Deaths Hosp.
Off label use 39,751 22.3% 6,335 11,201
Drug ineffective 32,186 18.0% 3,169 7,462
Rheumatoid arthritis 19,850 11.1% 2,167 5,477
Pain 16,675 9.3% 2,124 5,092
Fatigue 15,602 8.7% 2,477 5,183
Arthralgia 12,529 7.0% 1,864 4,945
Rash 12,102 6.8% 2,343 4,411
Drug intolerance 11,876 6.7% 1,703 3,314
Infusion related reaction 11,871 6.7% 2,239 4,458
Joint swelling 11,170 6.3% 2,145 4,040
Pneumonia 11,068 6.2% 3,093 5,544
Contraindicated product administered 10,479 5.9% 1,426 2,981
Nausea 10,250 5.7% 1,642 4,430
Alopecia 10,119 5.7% 1,721 3,105
Pyrexia 10,061 5.6% 2,054 5,833

Other Indications for RITUXIMAB

Rheumatoid arthritis (40,017) Product used for unknown indication (24,023) Diffuse large b-cell lymphoma (22,275) Chronic lymphocytic leukaemia (7,231) Non-hodgkin's lymphoma (5,959) Mantle cell lymphoma (3,940) Follicular lymphoma (3,294) Granulomatosis with polyangiitis (3,222) Lymphoma (3,142) Systemic lupus erythematosus (2,659)

Other Drugs Used for B-cell lymphoma

CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240) OBINUTUZUMAB (1,200)

Related Pages

RITUXIMAB Full Profile All B-cell lymphoma Drugs RITUXIMAB Demographics RITUXIMAB Timeline